Leukemia Research
Volume 27, Issue 7 , Pages 575-582, July 2003

Measurement of SILTAL1 fusion gene transcripts associated with human T-cell lymphocytic leukemia by real-time reverse transcriptase-PCR

  • John D. Curry

      Affiliations

    • Division of Immunology, Department of Molecular and Cellular Biology, University of California at Berkley, 439 Life Sciences Addition, Berkeley, CA 94720-3200, USA
  • ,
  • Martyn T. Smith

      Affiliations

    • Division of Environmental Health Sciences, School of Public Health, University of California, 216 Earl Warren Hall, Berkeley, CA 94720-7360, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-510-642-8770; fax: +1-510-642-0427.

Received 11 February 2002; accepted 4 October 2002.

Abstract 

TAL1 disruption at 1p32 [del(1p)] is a common rearrangement in the development of T-cell acute lymphocytic leukemia (T-ALL). The del(1p) are usually interstitial 90kb deletions placing TAL1 under control of the SCL interrupting locus (SIL) gene forming the SILTAL1 fusion product. A reverse transcriptase real-time PCR assay to quantify SILTAL1 fusion genes is described. A SILTAL1 fusion gene RNA transcript was built that permitted absolute standard curves to be generated. Sensitivity of the RT-PCR assay was determined to be 10 cells (CEM cell line) in 106 human lymphocytes. Peripheral blood lymphocytes from 10 healthy adults and 10 neonates were assayed. None of the samples showed any SILTAL1 expression. However, when lymphocytes from three adults were cultured in vitro the SILTAL1 transcript was detectable in the RNA isolates. No RAG2 expression was detected in these expanded samples, suggesting that the clones bearing the SILTAL1 fusion gene may have existed at low levels prior to the ex vivo expansion.

Keywords: SILTAL1, Real-time PCR, Lymphocytic leukemia, Childhood, Translocation

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0145-2126(02)00260-6

doi:10.1016/S0145-2126(02)00260-6

Leukemia Research
Volume 27, Issue 7 , Pages 575-582, July 2003